Lipid peroxidation has long been viewed primarily as a destructive process—a chaotic,free radical-driven cascade culminating in membrane damage and cell death—althoughits beneficial aspects have been increasingly recognized over the past decades. However,a growing body of evidence challenges this inflexible hypothesis, as exemplified by therecent demonstration that lipoxin A4, a product of directed enzymatic lipid oxygenation,actively suppresses ferroptosis. In this review, we synthesize the emerging paradigm ofdirected lipid oxygenation as a regulated, adaptive mechanism that may function as aphysiologically regulated lipid antioxidant barrier. We contrast the stochastic chemistry ofnon-enzymatic lipid peroxidation with the stereospecific, enzymatically driven oxygenationcatalyzed primarily by lipoxygenases (LOXs), cyclooxygenases (PTGSs), and cytochromeP450 enzymes, and hypothesize that these two modes compete for polyunsaturated fattyacid (PUFA) substrates, thereby determining cellular outcomes. We further examine howenzymatic lipid oxygenation generates bioactive oxylipins, including specialized pro-resolving mediators (SPMs), that activate cytoprotective transcriptional programs such asthe NRF2 pathway. Central to this framework is the coupled operation of LOX-mediatedoxygenation and GPX4-mediated hydroperoxide detoxification: the protective outcomedepends on GPX4 as the gatekeeper that channels LOX products toward protective signal-ing rather than ferroptotic accumulation. The implications for ferroptosis are particularlyprofound: unchecked lipid peroxidation drives ferroptotic cell death, whereas directed en-zymatic lipid oxygenation may oppose it. Whether this constitutes an endogenous barrierremains a hypothesis, and our model does not depend on depletion of the PUFA substratepool. Finally, we outline therapeutic opportunities and outstanding questions for the field.